• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1992 - 1994年世界卫生组织西太平洋区域淋病奈瑟菌抗生素敏感性监测。世界卫生组织西太平洋区域淋球菌抗菌监测项目。

Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae in the WHO western Pacific region 1992-4. WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme.

出版信息

Genitourin Med. 1997 Oct;73(5):355-61. doi: 10.1136/sti.73.5.355.

DOI:10.1136/sti.73.5.355
PMID:9534743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1195891/
Abstract

OBJECTIVE

To describe the establishment and outcomes of a regional programme of continuing long term surveillance of antibiotic susceptibility of Neisseria gonorrhoeae over the period 1992-4.

METHODS

Laboratories in 17 countries in the WHO Western Pacific Region participated in a continuing programme of surveillance of the susceptibility of gonococci to an agreed group of antibiotics over 3 years. Established techniques were used and these included quality control and proficiency testing systems.

RESULTS

About 20,000 gonococci were examined over a 3 year period. Resistance to the penicillins through beta lactamase production or chromosomal mechanisms was widespread, with further changes evident over the 3 years. Spectinomycin resistance was infrequently encountered but high level tetracycline resistance was present in most participating centres, with some having high proportions of tetracycline resistant organisms. Quinolone resistance increased and became widespread throughout the region in the 3 years, ultimately involving all but one centre. Both the number and minimum inhibitory concentrations of quinolone resistant isolates increased markedly.

CONCLUSIONS

Patterns of gonococcal resistance to antibiotics continue to evolve, at times rapidly, and have the potential for wide and rapid dissemination. Regional surveillance programmes can be developed by using and expanding existing resources. Data thus derived were applied to the development of appropriate treatment regimens in the region, and emphasised further the need for a global expansion of the programme of integrated surveillance of gonococcal resistance.

摘要

目的

描述1992 - 1994年期间淋病奈瑟菌抗生素敏感性区域长期持续监测项目的建立及结果。

方法

世界卫生组织西太平洋区域17个国家的实验室参与了一项为期3年的持续项目,该项目监测淋球菌对一组商定抗生素的敏感性。采用既定技术,包括质量控制和能力验证系统。

结果

在3年期间共检测了约20000株淋球菌。通过产生β-内酰胺酶或染色体机制对青霉素产生耐药性的情况很普遍,且在这3年中出现了进一步变化。壮观霉素耐药情况很少见,但大多数参与中心存在高水平四环素耐药,一些中心四环素耐药菌株比例很高。喹诺酮耐药性在3年中增加并在整个区域广泛传播,最终除一个中心外所有中心都受到影响。喹诺酮耐药菌株的数量和最低抑菌浓度均显著增加。

结论

淋球菌对抗生素的耐药模式持续演变,有时变化迅速,且有广泛快速传播的可能性。可利用并扩展现有资源开展区域监测项目。由此获得的数据被应用于该区域适当治疗方案的制定,并进一步强调了全球扩大淋球菌耐药性综合监测项目的必要性。

相似文献

1
Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae in the WHO western Pacific region 1992-4. WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme.1992 - 1994年世界卫生组织西太平洋区域淋病奈瑟菌抗生素敏感性监测。世界卫生组织西太平洋区域淋球菌抗菌监测项目。
Genitourin Med. 1997 Oct;73(5):355-61. doi: 10.1136/sti.73.5.355.
2
Resistance in gonococci isolated in the WHO Western Pacific Region to various antimicrobials used in the treatment of gonorrhoea, 1997. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme-WHO WPR GASP.1997年世界卫生组织西太平洋区域分离出的淋球菌对治疗淋病所用各种抗菌药物的耐药性。世界卫生组织西太平洋淋球菌抗菌药物监测项目——世界卫生组织西太平洋区域淋球菌抗菌药物监测项目
Commun Dis Intell. 1998 Dec 24;22(13):288-91. doi: 10.33321/cdi.1998.22.62.
3
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1999. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme.1999年世界卫生组织西太平洋区域淋病奈瑟菌抗生素耐药性监测。世界卫生组织西太平洋区域淋球菌抗菌药物监测计划。
Commun Dis Intell. 2000 Sep;24(9):269-71. doi: 10.33321/cdi.2000.24.46.
4
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2001. World Health Organization.2001年世界卫生组织西太平洋区域淋病奈瑟菌抗生素耐药性监测。世界卫生组织。
Commun Dis Intell Q Rep. 2002;26(4):541-5. doi: 10.33321/cdi.2002.26.52.
5
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008.2007 - 2008年世界卫生组织西太平洋和东南亚地区淋病奈瑟菌抗生素耐药性监测
Commun Dis Intell Q Rep. 2010 Mar;34(1):1-7. doi: 10.33321/cdi.2010.34.1.
6
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2004.2004年世界卫生组织西太平洋区域淋病奈瑟菌抗生素耐药性监测
Commun Dis Intell Q Rep. 2006;30(1):129-32. doi: 10.33321/cdi.2006.30.7.
7
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002.2002年世界卫生组织西太平洋区域淋病奈瑟菌抗生素耐药性监测
Commun Dis Intell Q Rep. 2003;27(4):488-91. doi: 10.33321/cdi.2003.27.77.
8
Antimicrobial resistance in gonococci, WHO Western Pacific Region, 1996. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme.1996年世界卫生组织西太平洋区域淋球菌的抗菌药物耐药性。世界卫生组织西太平洋区域淋球菌抗菌药物监测项目。
Commun Dis Intell. 1997 Dec 25;21(23):349-53. doi: 10.33321/cdi.1997.21.60.
9
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the World Health Organization Western Pacific Region, 2003.2003年世界卫生组织西太平洋区域淋病奈瑟菌抗生素耐药性监测
Commun Dis Intell Q Rep. 2005;29(1):62-4. doi: 10.33321/cdi.2005.29.2.
10
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010.2010年世界卫生组织西太平洋和东南亚地区淋病奈瑟菌抗生素耐药性监测
Commun Dis Intell Q Rep. 2012 Mar 31;36(1):95-100. doi: 10.33321/cdi.2012.36.4.

引用本文的文献

1
Antimicrobial Resistance in Papua New Guinea: A Narrative Scoping Review.巴布亚新几内亚的抗菌药物耐药性:一项叙述性范围综述
Antibiotics (Basel). 2023 Nov 29;12(12):1679. doi: 10.3390/antibiotics12121679.
2
The Prevalence of Antimicrobial Resistant in Papua New Guinea: A Systematic Review and Meta-Analysis.巴布亚新几内亚抗菌药物耐药性的流行情况:系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Jan 28;19(3):1520. doi: 10.3390/ijerph19031520.
3
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.2011 - 2012年南京性传播疾病门诊有症状男性淋病奈瑟菌分离株的抗菌药物敏感性:对头孢曲松敏感性降低的分离株的遗传特征
BMC Infect Dis. 2014 Nov 27;14:622. doi: 10.1186/s12879-014-0622-0.
4
Neisseria gonorrhoeae non-susceptible to cephalosporins and quinolones in Northwest Ethiopia.埃塞俄比亚西北部对头孢菌素和喹诺酮不敏感的淋病奈瑟菌。
BMC Infect Dis. 2013 Sep 5;13:415. doi: 10.1186/1471-2334-13-415.
5
Antimicrobial resistance surveillance systems: Are potential biases taken into account?抗菌药物耐药性监测系统:是否考虑了潜在的偏倚?
Can J Infect Dis Med Microbiol. 2011 Winter;22(4):e24-8. doi: 10.1155/2011/276017.
6
Longitudinal analysis of the evolution and dissemination of Neisseria gonorrhoeae strains (Saskatchewan, Canada, 2005 to 2008) reveals three major circulating strains and convergent evolution of ciprofloxacin and azithromycin resistance.对淋病奈瑟菌菌株(加拿大萨斯喀彻温省,2005 年至 2008 年)的演变和传播进行的纵向分析表明,存在三种主要的循环菌株,并且对环丙沙星和阿奇霉素的耐药性呈趋同进化。
J Clin Microbiol. 2012 Dec;50(12):3823-30. doi: 10.1128/JCM.01402-12. Epub 2012 Sep 12.
7
An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.深入了解淋病奈瑟菌的耐药谱及耐药机制。
Indian J Med Res. 2011 Oct;134(4):419-31.
8
In-house growth-promoting transport system for Neisseria gonorrhoeae.淋病奈瑟菌的内部生长促进转运系统。
J Clin Microbiol. 2007 Aug;45(8):2743-4. doi: 10.1128/JCM.00344-07. Epub 2007 May 30.
9
Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.天然存在的喹诺酮耐药淋病奈瑟菌菌株对新型喹诺酮类药物的体外敏感性与GyrA和ParC变化的相关性
Antimicrob Agents Chemother. 2001 Mar;45(3):734-8. doi: 10.1128/AAC.45.3.734-738.2001.

本文引用的文献

1
Quinolone-resistant Neisseria gonorrhoeae isolated in Sydney, Australia, 1991 to 1995.1991年至1995年在澳大利亚悉尼分离出的耐喹诺酮淋病奈瑟菌。
Sex Transm Dis. 1996 Sep-Oct;23(5):425-8. doi: 10.1097/00007435-199609000-00014.
2
Global burden of the HIV pandemic.全球艾滋病大流行的负担。
Lancet. 1996 Jul 13;348(9020):99-106. doi: 10.1016/s0140-6736(96)01029-x.
3
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.非溃疡性性传播疾病作为女性感染HIV-1的危险因素:一项队列研究的结果
AIDS. 1993 Jan;7(1):95-102. doi: 10.1097/00002030-199301000-00015.
4
From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.来自疾病控制与预防中心。1992 - 1994年俄亥俄州和夏威夷州淋病奈瑟菌对氟喹诺酮类药物敏感性降低。
JAMA. 1994 Jun 8;271(22):1733-4.
5
Survey on antibiotic sensitivity of Neisseria gonorrhoeae strains isolated in China, 1987-1992.1987 - 1992年中国分离的淋病奈瑟菌菌株抗生素敏感性调查
Sex Transm Dis. 1994 Jul-Aug;21(4):237-40.
6
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.坦桑尼亚农村地区性传播疾病治疗改善对艾滋病毒感染的影响:随机对照试验
Lancet. 1995 Aug 26;346(8974):530-6. doi: 10.1016/s0140-6736(95)91380-7.
7
STD control for HIV prevention--it works!
Lancet. 1995 Aug 26;346(8974):518-9. doi: 10.1016/s0140-6736(95)91374-2.
8
Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance.香港产青霉素酶淋病奈瑟菌的快速减少与新出现的4-氟喹诺酮耐药性相关。
Genitourin Med. 1995 Jun;71(3):141-4. doi: 10.1136/sti.71.3.141.
9
Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline.一株对青霉素、环丙沙星和四环素耐药的淋病奈瑟菌传入英国。
Genitourin Med. 1995 Aug;71(4):265-6. doi: 10.1136/sti.71.4.265-a.
10
Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in British Columbia: an imported phenomenon.不列颠哥伦比亚省对环丙沙星敏感性降低的淋病奈瑟菌:一种输入性现象。
Can Commun Dis Rep. 1995 Aug 15;21(15):137-9.